Evidence map›Paper›PMID 34289969›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2021

Biomarkers of Inflammation and Oxidative Stress among Adult Former Smoker, Current E-Cigarette Users-Results from Wave 1 PATH Study.

Carol H Christensen, Joanne T Chang, Brian L Rostron, Hoda T Hammad, Dana M van Bemmel, Arseima Y Del Valle-Pinero, Baoguang Wang, Elena V Mishina, Lisa M Faulcon, Ana DePina and 17 more

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. DNA Methylation Patterns Associated with Tinnitus in Young Adults-A Pilot Study.Journal of the Association for Research in Otolaryngology : JARO · 2024
    Article
  11. Assessing the Relationship between Biomarkers of Exposure and Biomarkers of Potential Harm: PATH Study Wave 1 (2013 to 2014).Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 8 institutions in 2 countries.

Carol H ChristensenOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland. carol.christensen@fda.hhs.gov.
Joanne T ChangOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland.
Brian L RostronOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland.
Hoda T HammadOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland.ORCID 0000-0001-9569-5316
Dana M van BemmelOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland.
Arseima Y Del Valle-PineroOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland.
Baoguang WangOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland.
Elena V MishinaOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland.
Lisa M FaulconOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland.ORCID 0000-0002-2889-0039
Ana DePinaOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland.
La'Nissa Brown-BakerOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland.
Heather L KimmelNational Institute of Drug Abuse, Bethesda, Maryland.ORCID 0000-0001-8278-0095
Elizabeth LambertNational Institute of Drug Abuse, Bethesda, Maryland.
Benjamin C BlountDivision of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia.ORCID 0000-0003-4788-8169
Huber W VesperDivision of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
Lanqing WangDivision of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
Maciej L GoniewiczDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York.ORCID 0000-0001-6748-3068
Andrew HylandDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Mark J TraversDepartment of Health Behavior, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Dorothy K HatsukamiMasonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.ORCID 0000-0002-1108-2609
Raymond NiauraCollege of Global Public Health, New York University, New York, New York.ORCID 0000-0002-0856-3540
K Michael CummingsDepartment of Psychiatry & Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina.ORCID 0000-0002-7103-7017
Kristie A TaylorWestat, Rockville, Maryland.
Kathryn C EdwardsWestat, Rockville, Maryland.
Nicolette BorekOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland.
Bridget K AmbroseOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland.ORCID 0000-0001-9263-3056
Cindy M ChangOffice of Science, Center for Tobacco Products, FDA, Silver Spring, Maryland.ORCID 0000-0002-2103-8222
Tobacco Research Institute · CNNational Center for Environmental Health · USRoswell Park Comprehensive Cancer Center · USNational Institute on Drug Abuse · USWestat (United States) · USMedical University of South Carolina · USNew York University · USUniversity of Minnesota · US

Funding

Intramural FDA HHS FD999999NIDA NIH HHS HHSN271201100027CNIDA NIH HHS HHSN271201600001C
6 · The paper itself

Abstract

backgroundFormer smokers who currently use e-cigarettes have lower concentrations of biomarkers of tobacco toxicant exposure than current smokers. It is unclear whether tobacco toxicant exposure reductions may lead to health risk reductions.

methodsWe compared inflammatory biomarkers (high-sensitivity C-reactive protein, IL6, fibrinogen, soluble intercellular adhesion molecule-1) and an oxidative stress marker (F2-isoprostane) among 3,712 adult participants in Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health Study by tobacco user groups: dual users of cigarettes and e-cigarettes; former smokers who currently use e-cigarettes-only; current cigarette-only smokers; former smokers who do not currently use any tobacco; and never tobacco users. We calculated geometric means (GM) and estimated adjusted GM ratios (GMR).

resultsDual users experienced greater concentration of F2-isoprostane than current cigarette-only smokers [GMR 1.09 (95% confidence interval, CI, 1.03-1.15)]. Biomarkers were similar between former smokers who currently use e-cigarettes and both former smokers who do not use any tobacco and never tobacco users, but among these groups most biomarkers were lower than those of current cigarette-only smokers. The concentration of F2-isoprostane decreased by time since smoking cessation among both exclusive e-cigarette users (

conclusionsDual users have greater concentration of F2-isoprostane than smokers. Exclusive e-cigarette users have biomarker concentrations that are similar to those of former smokers who do not currently use tobacco, and lower than those of exclusive cigarette smokers. IMPACT: This study contributes to an understanding of the health effects of e-cigarettes.

Indexed as

Oxidative StressAdolescentAdultBiomarkersCigarette SmokingF2-IsoprostanesFemaleHumansLongitudinal StudiesMaleMiddle AgedVapingYoung AdultBiomarkersF2-Isoprostanes

Identifiers

PMID34289969
PMCPMC8500540
OpenAlexW3185543293

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.